Development of orally active cannabinoids for the treatment of glaucoma.
D000284:Administration, Oral; D002186:Cannabinoids / Q000008:administration & dosage / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D005901:Glaucoma / Q000188:drug therapy*; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D013997:Time Factors
D002186:Cannabinoids